Prognostic significance of BRCA1, ERCC1, RRM1, and RRM2 in patients with advanced non-small cell lung cancer receiving chemotherapy (Q85322930)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227663%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Prognostic significance of BRCA1, ERCC1, RRM1, and RRM2 in patients with advanced non-small cell lung cancer receiving chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227663%20AND%20SRC:MED&resulttype=core&format=json

non-small-cell lung carcinoma

16 February 2020

main subject

1 reference

Hui Zhao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227663%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Huawei Zhang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227663%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Yonghai Du

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227663%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Xiaomeng Gu

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227663%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

17 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227663%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227663%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227663%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227663%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

12679-12688

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227663%20AND%20SRC:MED&resulttype=core&format=json

Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients

16 February 2020

cites work

1 reference

12 December 2020

Overexpression of ribonucleotide reductase as a mechanism of resistance to 2,2-difluorodeoxycytidine in the human KB cancer cell line

1 reference

12 December 2020

ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine

1 reference

12 December 2020

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy

1 reference

12 December 2020

ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy

1 reference

12 December 2020

Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts.

1 reference

12 December 2020

Excision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy

1 reference

12 December 2020

Overexpression of catalytic subunit M2 in patients with ovarian cancer.

1 reference

12 December 2020

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

1 reference

12 December 2020

RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer

1 reference

12 December 2020

Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers.

1 reference

12 December 2020

Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy.

1 reference

12 December 2020

Expression of RRM1 and RRM2 as a novel prognostic marker in advanced non-small cell lung cancer receiving chemotherapy

1 reference

12 December 2020

Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data

1 reference

12 December 2020

Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer

1 reference

12 December 2020

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

1 reference

12 December 2020

High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer

1 reference

12 December 2020

Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy

1 reference

12 December 2020

Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy.

1 reference

12 December 2020

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

12 December 2020

Genetic variation in the DNA repair genes is predictive of outcome in lung cancer

1 reference

12 December 2020

Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer.

1 reference

12 December 2020

Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway

1 reference

12 December 2020

BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis

1 reference

12 December 2020

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage

1 reference

12 December 2020

RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness

1 reference

12 December 2020

Broad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasms

1 reference

12 December 2020

ERCC1 and BRCA1 mRNA expression predicts the clinical outcome of non-small cell lung cancer receiving platinum-based chemotherapy

1 reference

12 December 2020

Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro

1 reference

12 December 2020

Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine

1 reference

12 December 2020

BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy

1 reference

12 December 2020

RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine

1 reference

12 December 2020